Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Cytoreductive Surgery And Intraperitoneal Hyperthermic Chemotherapy For Peritoneal Surface Malignancy: Non-colorectal Indications.

P. Shen, J. Stewart, E. Levine
Published 2009 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1245/ASO.2003.03.067
Long-Term Survivorship and Quality of Life After Cytoreductive Surgery Plus Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Carcinomatosis
R. McQuellon (2003)
10.1136/oem.17.4.260
Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province
J. Wagner (1960)
10.1002/1097-0142(19921215)70:12<2969::AID-CNCR2820701239>3.0.CO;2-A
New strategies are needed in diffuse malignant mesothelioma
Kasi S. Sridhar (1992)
Hyperthermic peritoneal perfusion combined with anticancer chemotherapy as prophylactic treatment of peritoneal recurrence of gastric cancer.
N. Kaibara (1989)
10.1001/ARCHSURG.137.5.564
Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management.
M. Talamonti (2002)
10.1245/ASO.2004.09.008
Treatment of Peritoneal Carcinomatosis From Colorectal Cancer: Impact of Complete Cytoreductive Surgery and Difficulties in Conducting Randomized Trials
D. Élias (2004)
10.1016/S1470-2045(04)01425-1
Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia.
O. Glehen (2004)
10.1056/NEJMOA010187
Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction
J. Macdonald (2001)
10.1159/000018585
Prognostic Factors in Resected Primary Small Bowel Tumors
B. Brücher (1998)
10.1002/cncr.23553
Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer
A. di Giorgio (2008)
Malignant tumors of the small intestine : A review of 144 cases
North Jh (2000)
10.1046/J.1365-2168.2001.01701.X
Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei
A. Witkamp (2001)
10.1001/ARCHSURG.1991.01410270062011
Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study.
W. Sindelar (1991)
10.1002/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO;2-9
Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy
D. Elias (2001)
10.1007/s10434-006-9708-2
Appendiceal Neoplasms With Peritoneal Dissemination: Outcomes After Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy
J. Stewart (2006)
10.1002/jso.21083
Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer
C. Helm (2008)
10.1379/1466-1268(1998)003<0245:NMAATF>2.3.CO;2
Nuclear matrix as a target for hyperthermic killing of cancer cells.
J. R. Roti Roti (1998)
10.1007/s002689900560
Second-look Surgery after Cytoreduction and Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer: Analysis of Prognostic Features
A. Portilla (1999)
10.1007/s10434-001-0787-9
Surgical Debulking and Intraperitoneal Chemotherapy for Established Peritoneal Metastases From Colon and Appendix Cancer
A. Culliford (2001)
10.1200/JCO.1990.8.8.1335
Intraperitoneal carboplatin: favorable results in women with minimal residual ovarian cancer after cisplatin therapy.
J. Speyer (1990)
10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O
Peritoneal carcinomatosis from non‐gynecologic malignancies
B. Sadeghi (2000)
10.1245/ASO.2004.05.009
Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy With Mitomycin C for Peritoneal Carcinomatosis from Nonappendiceal Colorectal Carcinoma
P. Shen (2004)
10.1007/s00268-001-0067-7
Indications for Early Postoperative Intraperitoneal Chemotherapy of Advanced Gastric Cancer: Results of a Prospective Randomized Trial
W. Yu (2001)
10.1007/BF00299188
Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer
Y. Yonemura (2004)
10.1097/01.pas.0000202039.74837.7d
Pseudomyxoma Peritonei of Appendiceal Origin: A Clinicopathologic Analysis of 101 Patients Uniformly Treated at a Single Institution, With Literature Review
Robert F Bradley (2006)
10.1097/00006254-198304000-00020
Phase I and Pharmacological Studies of Adriamycin Administered Intraperitoneally to Patients with Ovarian Cancer
R. Ozols (1982)
10.3109/07357909909040593
Prognostic factors affecting survival in patients with colorectal carcinomatosis.
E. A. Marcus (1999)
10.1056/NEJMOA052985
Intraperitoneal cisplatin and paclitaxel in ovarian cancer.
D. Armstrong (2006)
10.1056/NEJMOA055531
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.
D. Cunningham (2006)
10.1056/NEJM199612263352603
Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.
D. Alberts (1996)
10.1200/JCO.1998.16.8.2620
Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study.
M. Markman (1998)
10.1093/JNCI/89.7.480
Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure.
R. Dedrick (1997)
10.1245/ASO.2004.10.928
Problems of Success and Problems of Failure: Recurrent Disease After Cytoreductive Surgery and Intraperitoneal Chemoperfusion
E. Levine (2004)
10.1097/01.sla.0000152015.76731.1f
Long-term Survival Following Treatment of Pseudomyxoma Peritonei: An Analysis of Surgical Therapy
T. Miner (2005)
10.1016/j.gassur.2005.06.016
Limited survival in patients with carcinomatosis from foregut malignancies after cytoreduction and continuous hyperthermic peritoneal perfusion
J. Farma (2007)
10.1200/JCO.2005.05.2456
Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment.
M. Markman (2006)
10.1016/j.gassur.2003.12.014
Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer
J. J. Hall (2007)
10.1007/PL00011727
Efficacy of intraperitoneal and intravenous chemotherapy and left upper abdominal evisceration for advanced gastric cancer
E. Nomura (2001)
10.1200/JCO.2003.04.150
Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.
A. Feldman (2003)
[Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy].
D. Elias (2003)
10.1053/EJSO.2001.1196
Mucinous adenocarcinoma of the small bowel with peritoneal seeding.
P. Marchettini (2002)
10.1007/s10434-999-0727-7
Results of Treatment of 385 Patients With Peritoneal Surface Spread of Appendiceal Malignancy
P. Sugarbaker (1999)
10.1080/09553009214550851
Effect of heat on induction and repair of DNA strand breaks in X-irradiated CHO cells.
E. Dikomey (1992)
10.1001/ARCHSURG.139.1.20
Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer.
O. Glehen (2004)
10.1245/ASO.2004.07.002
Peritonectomy and Intraperitoneal Hyperthermic Perfusion (IPHP): A Strategy That Has Confirmed its Efficacy in Patients with Pseudomyxoma Peritonei
M. Deraco (2004)
10.3816/CLC.2003.N.023
Chemotherapy for malignant pleural mesothelioma.
P. Jänne (2003)
10.1002/1097-0142(20000601)88:11<2512::AID-CNCR12>3.0.CO;2-J
Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis
A. Beaujard (2000)
10.1007/BF02524154
Impact of tumor resection (Rxn) and intraperitoneal (IP) chemotherapy (CHRx) on health related quality of life (HRQL) in patients (Pts) with peritoneal surface malignancies (PSM)
R. Alexander (2006)
Prospective trial for the treatment of malignant peritoneal mesothelioma.
B. Loggie (2001)
10.1016/J.YGYNO.2007.03.022
Intraperitoneal hyperthermic chemotherapy using carboplatin: a phase I analysis in ovarian carcinoma.
S. Lentz (2007)
Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally.
J. Speyer (1980)
New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival.
M. Torisu (1983)
10.1053/EJSO.2000.1021
Multimodal treatment of peritoneal carcinomatosis and sarcomatosis.
P. Pilati (2001)
10.1043/1543-2165(2006)130[1654:PSOHPI]2.0.CO;2
Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma.
C. Cerruto (2006)
10.1097/00000658-199402000-00002
Pseudomyxoma Peritonei Long‐Term Patient Survival with an Aggressive Regional Approach
D. Gough (1994)
10.1152/AJPRENAL.1985.248.3.F413
A distributed model of peritoneal-plasma transport: analysis of experimental data in the rat.
M. Flessner (1985)
10.1038/modpathol.3800067
Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers
J. Trupiano (2004)
10.1245/ASO.2001.8.1.65
Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors.
Samantha K. Hendren (2001)
10.1245/s10434-008-9967-1
A Phase I Trial of Oxaliplatin for Intraperitoneal Hyperthermic Chemoperfusion for the Treatment of Peritoneal Surface Dissemination from Colorectal and Appendiceal Cancers
J. Stewart (2008)
10.1016/S0895-4356(02)00534-6
Gastric cancer epidemiology and risk factors.
Jon R Kelley (2003)
10.1053/EJSO.2000.1033
Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis.
R. McQuellon (2001)
10.1378/CHEST.93.1.159
Prognostic factors in diffuse malignant pleural mesothelioma. A study of 167 patients.
E. Chailleux (1988)
10.1007/BF00685626
Intraperitoneal 5-fluoro-2′-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study
V. Israel (2004)
10.1136/oem.45.3.182
Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation, diagnosis, and causes of death.
J. Ribak (1988)
10.1056/NEJMRA050152
Advances in malignant mesothelioma.
B. Robinson (2005)
A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity.
G. Los (1992)
10.1002/JSO.20296
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma
Samuel P Jacks (2005)
10.1245/s10434-006-9185-7
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement
J. Esquivel (2006)
10.1200/JCO.2001.19.4.1001
Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Gr
M. Markman (2001)
Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis.
A. C. Sayag-Beaujard (1999)
In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C.
B. Barlogie (1980)
10.1200/JCO.1988.6.1.147
Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985.
K. Antman (1988)
10.1002/bjs.4695
Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion
Y. Yonemura (2005)
10.1200/JCO.2003.04.187
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
V. Verwaal (2003)
10.1002/JPS.2600751106
Interspecies scaling of regional drug delivery.
R. Dedrick (1986)
10.1200/JCO.2003.02.153
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.
R. Ozols (2003)
Pseudomyxoma peritonei syndrome.
P. Sugarbaker (1996)
10.1002/1097-0142(19880115)61:2<232::AID-CNCR2820610205>3.0.CO;2-U
Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C
S. Koga (1988)
10.1007/s10120-001-8012-x
Sequential methotrexate and 5-fluorouracil therapy for gastric cancer patients with peritoneal dissemination: a retrospective study
M. Tahara (2001)
10.1007/BF02303567
Small bowel cancer: A 30-year review
D. Frost (2006)
10.1016/S0748-7983(03)00149-5
Pseudomyxoma peritonei: a review of 62 cases.
S. van Ruth (2003)
10.1200/JCO.2004.10.012
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
O. Glehen (2004)
10.1002/(SICI)1097-0142(19990201)85:3<529::AID-CNCR3>3.0.CO;2-9
Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma
S. Fujimoto (1999)
Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.
B. Loggie (2000)
10.1002/1097-0142(19900101)65:1<65::AID-CNCR2820650115>3.0.CO;2-L
Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second‐look operation
T. Fujimura (1990)
10.1002/(SICI)1097-0142(19980915)83:6<1251::AID-CNCR27>3.0.CO;2-3
A Phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis
D. Bartlett (1998)
10.1007/s10434-001-0632-1
Outcome of Palliative Operations for Malignant Bowel Obstruction in Patients With Peritoneal Carcinomatosis From Nongynecological Cancer
S. Blair (2001)
10.1001/ARCHSURG.138.1.26
Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis.
P. Shen (2003)
10.1097/00000658-199502000-00002
Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy
P. Sugarbaker (1995)
10.1007/BF01225271
Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma
M. Markman (2005)
10.1007/BF02306613
Surgically debulked malignant pleural mesothelioma: Results and prognostic factors
H. Pass (2006)
10.1007/s10434-999-0582-6
Treatment of Primary Peritoneal Mesothelioma by Continuous Hyperthermic Peritoneal Perfusion (CHPP)
B. Park (1999)
10.1093/ANNONC/MDL428
A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma
T. Yan (2007)
10.1016/S0039-6060(96)80145-0
Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination.
Y. Yonemura (1996)
10.1016/0090-8258(90)90131-4
Intraperitoneal carboplatin in the treatment of minimal residual ovarian cancer.
P. Pfeiffer (1990)
10.1111/j.2042-7158.1994.tb03883.x
Pharmacokinetic Characteristics of 5‐Fluorouracil and Mitomycin C in Intraperitoneal Chemotherapy
T. Kuzuya (1994)
10.1007/s002800050721
Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model
P. Jacquet (1997)
10.1056/NEJME058308
Intraperitoneal chemotherapy comes of age.
S. Cannistra (2006)
10.1245/s10434-007-9487-4
A Systematic Review and Meta-analysis of the Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Gastric Cancer
T. Yan (2007)



This paper is referenced by
10.1007/978-3-319-51523-6_3
Treatment of Pseudomyxoma Peritonei from Non-appendiceal Primary Sites
P. Sugarbaker (2017)
10.1002/jso.22017
Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: A systematic review of survival, mortality, and morbidity
R. Gill (2011)
10.1007/978-94-007-4783-8_7
Hyperthermia and Intracavitary Chemotherapy in Prevention and Treatment of Malignant Effusions
Gianfranco Baronzio (2012)
10.1111/ans.12306
Cure for peritoneal metastases? An evidence‐based review
L. Ung (2013)
10.1016/j.soc.2012.07.002
Current status and future directions in gastric cancer with peritoneal dissemination.
G. Glockzin (2012)
10.1007/978-88-470-5711-1_22
Other Secondary Peritoneal Surface Malignancies
M. Cardi (2015)
10.1038/gt.2010.48
Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?
T. Pencavel (2010)
UvA-DARE ( Digital Academic Repository ) HIPEC treatment of peritoneal carcinomatosis in colorectal and gastric cancer
H. J. Braam (2015)
HIPEC treatment of peritoneal carcinomatosis in colorectal and gastric cancer
H. J. Braam (2015)
10.1007/978-1-4939-1423-4_21
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Reese W Randle (2015)
10.1177/000313481408000728
Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Gallbladder Cancer: A Retrospective Review
Reese W Randle (2014)
10.1007/978-94-007-4783-8
Malignant Effusions
M. Kiselevsky (2012)
10.1080/02656736.2017.1283065
Current status and future prospects of clinical trials on CRS + HIPEC for gastric cancer peritoneal metastases
Zhong-He Ji (2017)
10.21037/JGO-20-262
Intra-operative hyperthermic intraperitoneal chemotherapy for prevention and treatment of peritoneal metastases from gastric cancer: a narrative review
Zhong-He Ji (2020)
10.1007/s13193-020-01089-4
Aortic Resection with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a Case Report
P. Kammar (2020)
10.1186/s12957-015-0703-6
Cytoreduction and HIPEC in the treatment of “unconventional” secondary peritoneal carcinomatosis
M. Cardi (2015)
10.1007/978-3-030-28891-4_10
Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Peritoneal Metastasis of Gastric Cancer
Y. Yonemura (2020)
10.1016/j.critrevonc.2015.04.004
Selection of chemotherapy for hyperthermic intraperitoneal use in gastric cancer.
H. J. Braam (2015)
10.1515/pp-2017-0017
Uncommon indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Francis Zheng Yi Yee (2017)
Semantic Scholar Logo Some data provided by SemanticScholar